122 related articles for article (PubMed ID: 36510999)
21. Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver.
Zimmerman RL; Burke MA; Young NA; Solomides CC; Bibbo M
Cancer; 2001 Aug; 93(4):288-91. PubMed ID: 11507703
[TBL] [Abstract][Full Text] [Related]
22. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
McKnight R; Nassar A; Cohen C; Siddiqui MT
Cancer Cytopathol; 2012 Aug; 120(4):223-9. PubMed ID: 22298472
[TBL] [Abstract][Full Text] [Related]
23. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
Morrison C; Marsh W; Frankel WL
Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.
Atta IS
Histol Histopathol; 2021 Sep; 36(9):981-993. PubMed ID: 34254284
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma.
Varma V; Cohen C
Adv Anat Pathol; 2004 Sep; 11(5):239-49. PubMed ID: 15322490
[TBL] [Abstract][Full Text] [Related]
26. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.
Yan BC; Gong C; Song J; Krausz T; Tretiakova M; Hyjek E; Al-Ahmadie H; Alves V; Xiao SY; Anders RA; Hart JA
Am J Surg Pathol; 2010 Aug; 34(8):1147-54. PubMed ID: 20661013
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of clusterin immunostaining in hepatocellular carcinoma.
Li Y; Liu F; Zhou W; Zhang S; Chu P; Lin F; Wang HL
Diagn Pathol; 2020 Oct; 15(1):127. PubMed ID: 33054843
[TBL] [Abstract][Full Text] [Related]
28. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma.
Giedl J; Büttner-Herold M; Wach S; Wullich B; Hartmann A; Agaimy A
Hum Pathol; 2016 Sep; 55():101-7. PubMed ID: 27184483
[TBL] [Abstract][Full Text] [Related]
29. Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma.
Lagana SM; Salomao M; Remotti HE; Knisely AS; Moreira RK
Histopathology; 2015 Mar; 66(4):598-602. PubMed ID: 25378077
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Pitman MB; Triratanachat S; Young RH; Oliva E
Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.
Yao S; Zhang J; Chen H; Sheng Y; Zhang X; Liu Z; Zhang C
J Histochem Cytochem; 2013 Sep; 61(9):639-48. PubMed ID: 23686365
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples.
Siddiqui MT; Saboorian MH; Gokaslan ST; Ashfaq R
Cancer; 2002 Feb; 96(1):49-52. PubMed ID: 11836703
[TBL] [Abstract][Full Text] [Related]
33. Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma.
Sang W; Zhang W; Cui W; Li X; Abulajiang G; Li Q
Tumour Biol; 2015 May; 36(5):3881-6. PubMed ID: 25577247
[TBL] [Abstract][Full Text] [Related]
34. Role of glypican-3 immunocytochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver utilizing fine needle aspiration cytology.
Zaakook M; Ayoub M; Sinna EA; El-Sheikh S
J Egypt Natl Canc Inst; 2013 Dec; 25(4):173-80. PubMed ID: 24207089
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic utility of Glut-1 and CA 15-3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration.
Zimmerman RL; Burke M; Young NA; Solomides CC; Bibbo M
Cancer; 2002 Feb; 96(1):53-7. PubMed ID: 11836704
[TBL] [Abstract][Full Text] [Related]
36. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
de Boer WB; Segal A; Frost FA; Sterrett GF
Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
[TBL] [Abstract][Full Text] [Related]
37. Fine needle aspiration cytodiagnosis of liver tumors.
Kuo FY; Chen WJ; Lu SN; Wang JH; Eng HL
Acta Cytol; 2004; 48(2):142-8. PubMed ID: 15085744
[TBL] [Abstract][Full Text] [Related]
38. Loss of 5-hydroxymethylcytosine immunohistochemical expression is a useful diagnostic aid for distinguishing hepatocellular carcinoma in cytology fine needle aspiration specimens.
Zhu X; Dresser K; Chen BJ
Cytopathology; 2019 Sep; 30(5):492-498. PubMed ID: 31081979
[TBL] [Abstract][Full Text] [Related]
39. Metastatic hepatocellular carcinoma of skin diagnosed with hepatocyte paraffin 1 and a-fetoprotein immunostainings.
Terada T; Sugiura M
Int J Surg Pathol; 2010 Oct; 18(5):433-6. PubMed ID: 18499685
[TBL] [Abstract][Full Text] [Related]
40. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
Xiao SY; Wang HL; Hart J; Fleming D; Beard MR
Am J Pathol; 2001 Oct; 159(4):1415-21. PubMed ID: 11583969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]